LifeTime and improving European healthcare through cell-based interceptive medicine

Area of Science:

• Biomedical research
• Cell biology
• Computational biology

Background:

• Complex diseases pose significant health challenges.
• Understanding cellular mechanisms is crucial for disease interception.
• Current therapeutic strategies require advancement for personalized treatment.

Purpose of the Study:

• To track and understand human cells during disease onset and progression.
• To analyze cellular responses to therapy at single-cell resolution.
• To develop cell-based interceptive medicine.

Main Methods:

• Integrating single-cell multi-omics and imaging.
• Utilizing artificial intelligence (AI) and patient-derived disease models.
• Analyzing large molecular and clinical datasets.

Main Results:

• Identification of molecular mechanisms driving disease.
• Creation of predictive computational models for disease progression.
• Discovery of novel drug targets and therapeutic strategies.

Conclusions:

• The LifeTime Initiative will advance cell-based interceptive medicine.
• This approach promises timely disease detection and intervention.
• Cross-sectoral collaboration is key to achieving these goals.